menu
    • menu

    Company profile for Sumitomo Pharma Oncology

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, the DSP Cancer Institute, and the Oncology Clinical Development Unit, will collectively be known as Sumitomo Pharma Oncology. SP Oncology brings together a team of highly engaged oncology expe...
    Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, the DSP Cancer Institute, and the Oncology Clinical Development Unit, will collectively be known as Sumitomo Pharma Oncology. SP Oncology brings together a team of highly engaged oncology experts who leverage their passion for challenging work to collaborate across geographies and realize a common goal—advancing purposeful science by transforming new discoveries.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sumitomo Pharma OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge Innovation Center (CIC) 245 Main Street, Kendall Square Cambridge, M...
    Telephone
    Telephone
    +91 6176746800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://oncology.sumitomo-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/smponcology/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sumitomo Pharma Oncology to Present Preliminary Data Evaluating TP-3654
    Sumitomo Pharma Oncology to Present Preliminary Data Evaluating TP-3654

    03 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-oncology-to-present-preliminary-clinical-data-evaluating-investigational-agent-tp-3654-at-the-64th-ash-annual-meeting--exposition-301667810.html

    PRNEWSWIRE
    03 Nov 2022
    Share Share
    Sumitomo Pharma Oncology Receives ODD for DSP-0390 for Brain Cancer
    Sumitomo Pharma Oncology Receives ODD for DSP-0390 for Brain Cancer

    18 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-oncology-receives-orphan-drug-designation-for-dsp-0390-an-investigational-emopamil-binding-protein-ebp-inhibitor-for-the-treatment-of-brain-cancer-301587648.html

    PRNEWSWIRE
    18 Jul 2022
    Share Share
    Sumitomo Presents New Data from Novel Cancer Therapeutics at AACR
    Sumitomo Presents New Data from Novel Cancer Therapeutics at AACR

    08 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-oncology-presents-new-data-from-investigational-pipeline-of-novel-cancer-therapeutics-at-aacr-annual-meeting-2022-301521150.html

    PRNEWSWIRE
    08 Apr 2022
    Share Share
    Sumitomo Dainippon Provides Update on Phase 3 Study of DSP-7888 in Glioblastoma
    Sumitomo Dainippon Provides Update on Phase 3 Study of DSP-7888 in Glioblastoma

    14 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-provides-update-on-phase-3-wizard-201g-study-of-ombipepimut-s-emulsion-dsp-7888-in-patients-with-recurrent-or-progressive-glioblastoma-301444814.html

    PRNEWSWIRE
    14 Dec 2021
    Share Share
    Sumitomo Begins Dosing in Phase 1 Dose Expansion Study of TP-1287
    Sumitomo Begins Dosing in Phase 1 Dose Expansion Study of TP-1287

    03 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-announces-first-patient-dosed-in-phase-1-dose-expansion-study-of-tp-1287-in-patients-with-sarcoma-301414798.html

    PRNEWSWIRE
    03 Nov 2021
    Share Share
    Sumitomo Dainippon Pharma Oncology Announces Phase 3 CanStem303C Study
    Sumitomo Dainippon Pharma Oncology Announces Phase 3 CanStem303C Study

    09 Feb 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-announces-phase-3-canstem303c-study-of-napabucasin-fails-to-reach-primary-endpoints-in-patients-with-previously-treated-metastatic-colorectal-cancer-301224902.html

    PRNEWSWIRE
    09 Feb 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search